Loading

Mediwhale Inc.

June 04, 2024
Company Presentation
AI and Digital Health
Company Presentation Theater 3
Mediwhale: Revolutionizing Metabolic Care with AI At Mediwhale, we transform cardio-metabolic health in primary care. Our personalized AI solutions prioritize accessibility and safety, ensuring better outcomes. Reti-CVD: Our cutting-edge AI analyzes retinal blood vessels, precisely calculating future cardio-metabolic disease risk. It outperforms standard tests and is comparable to cardiac CT scans in accuracy. Commercialization: Regulatory approvals in eight territories, including Europe, the UK, Australia, Singapore, and Korea, position Reti-CVD as the novel standard for cardio-metabolic care. As the first code for outpatient cases in the Korean market, Reti-CVD secures reimbursement, driving adoption among primary care doctors. Global Impact: Healthcare professionals recognize Reti-CVD as the innovative solution for cardio-metabolic care.
Mediwhale Inc.
Company Website: http://www.mediwhale.com
Lead Product in Development: Reti-CVD - SaMD: Cardiovascular risk assessment SW (3rd grade medical device in Korea) - Cardiovascular disease risk prediction
Number Of Unlicensed Products (For Which You Are Seeking Partners): 2

Company HQ City

Seoul

Company HQ State

Seoul

Company HQ Country

Korea, Republic of

CEO/Top Company Official

CEO | Kevin Choi - A young and rapidly growing digital healthcare entrepreneur. CMO | Tyler Rim - An accomplished clinical scientist, recognized as one of the “TOP 2% scientists in the world in 2022” by Stanford and Elsevier. - Holds a dual role as an ophthalmologist and a Ph.D. - Also possesses an M.B.A. CTO | Alex Nam - A leading expert in artificial intelligence (AI). - Notable achievements include contributions to conferences such as NIPS(1), CVPR(3), ICCV(1), and ECCV(1). CPO | Young Lee - A seasoned professional with extensive experience in software as a medical device. - Distinguished as the main author of top medical journals, including The Lancet Digital Health. COO | Nina Shin - Demonstrates exceptional skills in operation and management. - Holds an M.B.A. from Harvard University.

Development Phase of Primary Product

NDA Preparation/In Review
Speakers
Kevin Choi
CEO
Mediwhale
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS